Credit Suisse Ag Biolife Solutions Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Biolife Solutions Inc stock. As of the latest transaction made, Credit Suisse Ag holds 36,281 shares of BLFS stock, worth $943,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,281

Previous 35,950 0.92%

Holding current value

$943,668

Previous $584,000 15.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$15.35 - $18.82 $5,080 - $6,229	331 Added 0.92%	36,281 $673,000
Q4 2023 Feb 08, 2024	BUY	$8.99 - $16.86 $3,856 - $7,232	429 Added 1.21%	35,950 $584,000
Q3 2023 Nov 13, 2023	SELL	$10.81 - $22.96 $39,261 - $83,390	-3,632 Reduced 9.28%	35,521 $490,000
Q2 2023 Aug 11, 2023	BUY	$17.19 - $24.34 $181,096 - $256,421	10,535 Added 36.81%	39,153 $865,000
Q1 2023 May 10, 2023	BUY	$17.67 - $26.07 $159 - $234	9 Added 0.03%	28,618 $622,000
Q4 2022 Feb 13, 2023	SELL	$16.95 - $25.07 $26,899 - $39,786	-1,587 Reduced 5.26%	28,609 $520,000
Q3 2022 Nov 10, 2022	BUY	$14.64 - $26.7 $98,629 - $179,877	6,737 Added 28.72%	30,196 $687,000
Q2 2022 Aug 12, 2022	BUY	$10.54 - $24.2 $25,928 - $59,532	2,460 Added 11.71%	23,459 $323,000
Q1 2022 May 16, 2022	BUY	$20.81 - $37.29 $28,967 - $51,907	1,392 Added 7.1%	20,999 $477,000
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $49,089 - $87,122	1,488 Added 8.21%	19,607 $732,000
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $102,090 - $146,954	2,429 Added 15.48%	18,119 $767,000
Q2 2021 Aug 16, 2021	SELL	$29.51 - $44.62 $118,718 - $179,506	-4,023 Reduced 20.41%	15,690 $698,000
Q1 2021 May 14, 2021	SELL	$32.95 - $44.24 $141,223 - $189,612	-4,286 Reduced 17.86%	19,713 $709,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $45.75 $659,972 - $1.1 Million	23,999 New	23,999 $957,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account